 N-myc genomic content DNA ploidy stage IVS neuroblastoma DNA ploidy N-myc genomic content series stage IVS neuroblastomas flow cytometry Southern blot hybridization stage IVS aneuploid DNA index DI diploid DI assessable DNA content due insufficient tumor material N-myc gene amplification present tumors None aneuploid tumors N-myc amplification aneuploid neuroblastomas DIs ie near-triploid range follow-up diagnosis months months neuroblastomas near-triploid DNA content free disease end follow-up period contrast rapid fatal tumor progression neuroblastomas N-myc amplification and/or diploidy limited series results combined analysis DNA ploidy N-myc genomic content clinical outcome stage IVS neuroblastoma patients aggressive therapy